Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Reham Atteya"'
Autor:
Nehal Adel Abdelsalam, Shahira A. ElBanna, Shaimaa F. Mouftah, José F. Cobo-Díaz, Ahmed H. Shata, Sherine M. Shawky, Reham Atteya, Mohamed Elhadidy
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)
Abstract Background Ongoing studies have revealed the global prevalence of severe infections caused by the hypervirulent strains of Klebsiella pneumoniae (K. pneumoniae). Meanwhile, the World Health Organization and the Centers for Disease Control de
Externí odkaz:
https://doaj.org/article/e6ece4ecdf1d45c29d417efcc326eccb
Autor:
Salma Salem, Nehal Adel Abdelsalam, Ahmed H. Shata, Shaimaa F. Mouftah, José F. Cobo-Díaz, Dina Osama, Reham Atteya, Mohamed Elhadidy
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The incidence of Pseudomonas aeruginosa infections in healthcare environments, particularly in low-and middle-income countries, is on the rise. The purpose of this study was to provide comprehensive genomic insights into thirteen P. aerugino
Externí odkaz:
https://doaj.org/article/06e510657fad478fbaa934f95f8c198b
Autor:
Fatma Abdelrahman, Nouran Rezk, Mohamed S. Fayez, Mohamed Abdelmoteleb, Reham Atteya, Mohamed Elhadidy, Ayman El-Shibiny
Publikováno v:
Microorganisms, Vol 10, Iss 3, p 589 (2022)
Escherichia coli (E. coli) is one of the most common pathogenic bacteria worldwide. Avian pathogenic E. coli (APEC) causes severe systemic disease in poultry (Colibacillosis), and accordingly, has an extreme risk to the poultry industry and public he
Externí odkaz:
https://doaj.org/article/83a5fa0db5f6445c84e4d50f0f3f2eba
Autor:
Marwa Matboli, Mohmed Kamal Hassan, Mahmoud A. Ali, Mohamed Tarek Mansour, Waheba Elsayed, Reham Atteya, Hebatallah Said Aly, Mahmoud El Meteini, Hesham Elghazaly, Sherif El-Khamisy, Sara H. A. Agwa
Publikováno v:
Pharmaceutics, Vol 14, Iss 1, p 138 (2022)
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death in Egypt. A deep understanding of the molecular events occurring in HCC can facilitate the development of novel diagnostic and/or therapeutic approaches. In the present study,
Externí odkaz:
https://doaj.org/article/26045417af394f50943e0db6d1bf4a63
Autor:
Fatma, Abdelrahman, Nouran, Rezk, Mohamed S, Fayez, Mohamed, Abdelmoteleb, Reham, Atteya, Mohamed, Elhadidy, Ayman, El-Shibiny
Publikováno v:
Microorganisms. 10(3)
Autor:
Sherif F. El-Khamisy, Sameh Magdeldin, Reham Atteya, Menattallah Elserafy, Walaa R. Allam, Mohamed K. Hassan, Waheba Elsayed, Mohamed E. Ashour
Publikováno v:
Cancers
Cancers, Vol 13, Iss 2315, p 2315 (2021)
Volume 13
Issue 10
Cancers, Vol 13, Iss 2315, p 2315 (2021)
Volume 13
Issue 10
Simple Summary Targeting topoisomerases has been widely used as anticancer therapeutics. Exposure to high temperature (hyperthermia) protects cells from the cytotoxic effect of topoisomerase-targeting therapeutics, yet the mechanism remains unknown.
Autor:
Abdelrahman AlOkda, Mohamed M Abdrabbou, Reham Atteya, Sherif F. El-Khamisy, Menattallah Elserafy, Iman El-Shiekh, Mostafa Nasr, Dalia Fleifel
Publikováno v:
Life Science Alliance
Ribonucleoside incorporation in genomic DNA poses a significant threat to genomic integrity. Here, we describe how cells tolerate this threat and discuss implications for cancer therapeutics.
Ribonucleoside monophosphate (rNMP) incorporation in
Ribonucleoside monophosphate (rNMP) incorporation in
Publikováno v:
Trends in Genetics
Not only have helicase-like transcription factor (HLTF) and SNF2 histone-linker PHD-finger RING-finger helicase (SHPRH) proved to be important players in post-replication repair like their yeast counterpart, Rad5, but they are also involved in multip
Publikováno v:
Nature Reviews Cancer. 15:137-151
The mammalian genome is constantly challenged by exogenous and endogenous threats. Although much is known about the mechanisms that maintain DNA and RNA integrity, we know surprisingly little about the mechanisms that underpin the pathology and tissu
Publikováno v:
Mechanisms of ageing and development. 161
Despite being an invaluable chemotherapeutic agent for several types of cancer, the clinical utility of doxorubicin is hampered by its age-related and dose-dependent cardiotoxicity. Co-administration of dexrazoxane as a cardioprotective agent has bee